US 12064473
Cancer vaccines targeting Survivin and uses thereof
granted A61KA61K2039/53A61K2039/55527
Quick answer
US patent 12064473 (Cancer vaccines targeting Survivin and uses thereof) held by Inovio Pharmaceuticals, Inc. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/53, A61K2039/55527, A61K2039/575, A61K39/00115